• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型慢性髓系白血病的临床、血液学及细胞遗传学特征

Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.

作者信息

Hernández J M, del Cañizo M C, Cuneo A, García J L, Gutiérrez N C, González M, Castoldi G, San Miguel J F

机构信息

Department of Hematology, Hospital Universitario and Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC, Spain.

出版信息

Ann Oncol. 2000 Apr;11(4):441-4. doi: 10.1023/a:1008393002748.

DOI:10.1023/a:1008393002748
PMID:10847463
Abstract

BACKGROUND

Atypical chronic myeloid leukemia (aCML) is an infrequent chronic myeloproliferative disorder characterized by leukocytosis, absence of Philadelphia chromosome or BCR-ABL rearrangement, and marked myeloid dysplasia. Some cases have an absolute monocytosis but can be distinguished from chronic myelomonocytic leukemia (CMML) by the presence of a higher percentage (> 15%) of circulating immature granulocytes.

PATIENTS AND METHODS

In a series of 11 patients with a diagnosis of aCML according to the FAB proposals we have analyzed the most relevant clinical, hematological and cytogenetic characteristics.

RESULTS

The median age was 65 years (16-84). All but one case showed, at time of diagnosis, leukocytosis (median WBC was 36 x 10(9)/l), 55% had moderate anemia and 36% had thrombocytopenia. Most cases had marked dysplasia, particularly in the granulocytic lineage (82% of the cases), and all cases showed bone marrow red hypoplasia. Cytogenetic abnormalities were present in 9 out of the 11 patients. Trisomy 8 was observed in three cases and other clonal chromosomal abnormalities included deletions of 5q, 13q, 17p, 12q, and 11q as well as a t(6;8)(p23;q22) translocation. Fluorescence in situ hybridization (FISH) studies failed to demonstrate ETV-6 gene involvement. The median survival time from diagnosis was only 14 months (range 3-56 months).

CONCLUSIONS

These data suggest that aCML is a rare disease which is characterized by leukocytosis, with dysgranulopoiesis, BM erythroid hypoplasia, chromosomal, though not recurrent, abnormalities and poor prognosis.

摘要

背景

非典型慢性髓系白血病(aCML)是一种罕见的慢性骨髓增殖性疾病,其特征为白细胞增多、无费城染色体或BCR-ABL重排以及明显的髓系发育异常。部分病例存在绝对单核细胞增多,但可通过循环中未成熟粒细胞比例较高(>15%)与慢性粒-单核细胞白血病(CMML)相鉴别。

患者与方法

在一组根据FAB标准诊断为aCML的11例患者中,我们分析了其最相关的临床、血液学和细胞遗传学特征。

结果

中位年龄为65岁(16 - 84岁)。除1例患者外,所有病例在诊断时均表现为白细胞增多(中位白细胞计数为36×10⁹/L),55%有中度贫血,36%有血小板减少。多数病例有明显的发育异常,尤其是粒细胞系(82%的病例),所有病例均显示骨髓红系增生低下。11例患者中有9例存在细胞遗传学异常。3例观察到8号染色体三体,其他克隆性染色体异常包括5q、13q、17p、12q和11q缺失以及t(6;8)(p23;q22)易位。荧光原位杂交(FISH)研究未显示ETV-6基因受累。从诊断开始的中位生存时间仅为14个月(范围3 - 56个月)。

结论

这些数据表明,aCML是一种罕见疾病,其特征为白细胞增多、粒细胞生成异常、骨髓红系增生低下、染色体异常(虽不具有重复性)以及预后不良。

相似文献

1
Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.非典型慢性髓系白血病的临床、血液学及细胞遗传学特征
Ann Oncol. 2000 Apr;11(4):441-4. doi: 10.1023/a:1008393002748.
2
The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.外周血、骨髓穿刺液,尤其是骨髓活检切片在鉴别不典型慢性髓细胞白血病与慢性粒细胞白血病及慢性粒单核细胞白血病中的作用。
Eur J Haematol. 2009 Oct;83(4):292-301. doi: 10.1111/j.1600-0609.2009.01283.x. Epub 2009 Jun 2.
3
[Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].[费城染色体阴性白血病性疾病的诊断谱]
Pathologe. 2002 Nov;23(6):448-56. doi: 10.1007/s00292-002-0585-6. Epub 2002 Oct 19.
4
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.费城染色体阴性、bcr/abl阴性慢性粒细胞白血病患者的特征及预后
Cancer. 2002 Oct 15;95(8):1673-84. doi: 10.1002/cncr.10832.
5
Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.一系列Ph阴性慢性髓性白血病的临床、形态学、细胞遗传学及分子学特征
Hematol Cell Ther. 1998 Aug;40(4):149-58.
6
[Atypical chronic myeloid leukemia presenting with trilineage dysplasia and IgG (lambda) type monoclonal gammopathy].[伴有三系发育异常及IgG(λ)型单克隆丙种球蛋白病的非典型慢性髓系白血病]
Rinsho Ketsueki. 1999 Feb;40(2):129-34.
7
Atypical chronic myeloid leukemia in a German Shepherd Dog.一只德国牧羊犬患非典型慢性髓性白血病。
J Vet Diagn Invest. 2017 May;29(3):338-345. doi: 10.1177/1040638716689581. Epub 2017 Feb 16.
8
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.伴有断裂点簇集区重排的费城染色体阴性慢性粒细胞白血病。长期随访结果。
Cancer. 1995 Jan 15;75(2):464-70. doi: 10.1002/1097-0142(19950115)75:2<464::aid-cncr2820750209>3.0.co;2-e.
9
p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?p190 bcr-abl重排:某些慢性髓系疾病中的一种继发性细胞遗传学事件?
Haematologica. 1999 Dec;84(12):1075-80.
10
Spectral karyotyping refined the identification of a der(Y)t(Y;1)(q11.1 or.2;q12) in the blast cells of a patient with atypical chronic myeloid leukemia.光谱核型分析改进了对一名非典型慢性髓性白血病患者原始细胞中der(Y)t(Y;1)(q11.1或.2;q12)的识别。
Acta Haematol. 2002;107(4):224-9. doi: 10.1159/000058319.

引用本文的文献

1
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia.miR-15a 靶向慢性髓性白血病中的 HSP90 共伴侣 Morgana。
Sci Rep. 2024 Jul 2;14(1):15089. doi: 10.1038/s41598-024-65404-7.
2
Atypical CML: diagnosis and treatment.非典型慢性髓性白血病:诊断与治疗。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):476-482. doi: 10.1182/hematology.2023000448.
3
Characteristics, primary treatment, and survival of MDS/MPN with neutrophilia: a population-based study.伴有中性粒细胞增多的 MDS/MPN 的特征、主要治疗方法和生存情况:一项基于人群的研究。
Blood Adv. 2023 Dec 26;7(24):7554-7563. doi: 10.1182/bloodadvances.2023011181.
4
A rare case of aCML associated with CNS involvement and with aggressive clinical course.一例罕见的伴有中枢神经系统受累且临床病程侵袭性的慢性粒细胞白血病。
Leuk Res Rep. 2023 Jan 11;19:100361. doi: 10.1016/j.lrr.2023.100361. eCollection 2023.
5
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.ABNL-MARRO 001 研究:一项在 MDS/MPN 重叠综合征中随机分配活性髓系靶向化合物组合的 1-2 期研究。
BMC Cancer. 2022 Sep 24;22(1):1013. doi: 10.1186/s12885-022-10073-w.
6
Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms.审视疾病界限:骨髓增生异常/骨髓增殖性肿瘤的遗传学
EJHaem. 2021 Jul 19;2(3):607-615. doi: 10.1002/jha2.264. eCollection 2021 Aug.
7
Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer.为服务于希腊精准医学癌症网络而建立罕见恶性肿瘤生物银行的基础。
Int J Oncol. 2022 Mar;60(3). doi: 10.3892/ijo.2022.5321. Epub 2022 Feb 16.
8
Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.混合性或重叠性骨髓增生异常/骨髓增殖性疾病——流行病学特征与概述
Front Oncol. 2021 Nov 16;11:778741. doi: 10.3389/fonc.2021.778741. eCollection 2021.
9
Atypical Chronic Myelogenous Leukemia, Negative: Diagnostic Criteria and Treatment Approaches.非典型慢性髓系白血病,阴性:诊断标准与治疗方法
Front Oncol. 2021 Nov 17;11:722507. doi: 10.3389/fonc.2021.722507. eCollection 2021.
10
Molecular Pathogenesis of -Negative Atypical Chronic Myeloid Leukemia.阴性非典型慢性髓系白血病的分子发病机制
Front Oncol. 2021 Nov 11;11:756348. doi: 10.3389/fonc.2021.756348. eCollection 2021.